- About the Study
- A study in participants with moderately to severely active Rheumatoid Arthritis.
- What does the study involve?
- Participants will receive investigational product or placebo for approximately 12 weeks.
- Who can participate?
- To be eligible for inclusion into the study, a patient must meet the following criteria: (1) Adults and older adults of all sexes (18 years and older). (2) Have a diagnosis of adult-onset rheumatoid arthritis (RA) for at least 3 months prior to screening. (3) Have moderately-to-severely active RA, at screening and baseline, defined by the presence of ≥6 swollen joints based on 66 joint count, and ≥6 tender joints based on 68 joint count. (4) Have had an inadequate response to, or loss of response or intolerance to at least 1 conventional synthetic, or targeted synthetic treatment.
- Where is the study taking place?
- The study is being conducted at our Boynton Beach office.
- Is compensation provided?
- Yes